Charles Schwab
NAUT icon

Charles Schwab’s Nautilus Biotechnolgy NAUT Stock Holding History

Charles Schwab’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Buy
+123,684
New +$327K ﹤0.01% 3360
2025
Q2 		– Sell
-115,418
Closed -$99.4K – 3542
2025
Q1 		$99.4K Buy
115,418
+187
+0.2% +$278 ﹤0.01% 3342
2024
Q4 		$194K Sell
115,231
-22,256
-16% -$53.2K ﹤0.01% 3333
2024
Q3 		$392K Hold
137,487
– – ﹤0.01% 3220
2024
Q2 		$322K Buy
137,487
+1,133
+0.8% +$2.96K ﹤0.01% 3349
2024
Q1 		$401K Hold
136,354
– – ﹤0.01% 3108
2023
Q4 		$408K Sell
136,354
-9,124
-6% -$26.1K ﹤0.01% 3151
2023
Q3 		$460K Buy
145,478
+7,662
+6% +$24.9K ﹤0.01% 3073
2023
Q2 		$533K Buy
137,816
+6,213
+5% +$17.9K ﹤0.01% 3021
2023
Q1 		$365K Buy
131,603
+4,597
+4% +$9.64K ﹤0.01% 3043
2022
Q4 		$229K Hold
127,006
– – ﹤0.01% 3160
2022
Q3 		$270K Hold
127,006
– – ﹤0.01% 3126
2022
Q2 		$342K Buy
127,006
+104,750
+471% +$390K ﹤0.01% 3172
2022
Q1 		$97K Hold
22,256
– – ﹤0.01% 3420
2021
Q4 		$116K Hold
22,256
– – ﹤0.01% 3422
2021
Q3 		$137K Buy
+22,256
New +$177K ﹤0.01% 3352

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Charles Schwab's NAUT Position: Q2 2026 in Review

Charles Schwab opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 123,684 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #3360 among its holdings. This is a return to the name: Charles Schwab previously reported a position in NAUT as recently as Q1 2025.

Charles Schwab first reported a position in NAUT in Q3 2021 and has held it in 16 quarters since. The position peaked at $533K in Q2 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Charles Schwab held 123,684 shares of Nautilus Biotechnolgy worth $231K as of Q2 2026.
  • Nautilus Biotechnolgy was a new Charles Schwab position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3360 holding.
  • Charles Schwab first reported a position in Nautilus Biotechnolgy in Q3 2021 and has held it in 16 quarters since.
  • Charles Schwab's Nautilus Biotechnolgy position peaked at $533K in Q2 2023.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.